Altre lingue ARYA Sciences Acquisition Corp IV

Azioni

ARYD

KYG316591083

Tempo differito Nasdaq Altri mercati azionari 16:35:09 23/04/2024			Variaz. 5gg	Var. 1 gen.
11,35 ^USD	+0,35%		+0,35%	+4,13%

29/03	ARYA Sciences Acquisition Corp IV riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	ARYA Sciences Acquisition Corp IV riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
ARYA Sciences Acquisition IV : Failure to Satisfy Listing Rule - Form 8-K	29/03
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies	14/02
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	08/02
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	03/10/23
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV	27/09/23
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	05/09/23
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	02/08/23
ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination	03/07/23
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV	02/06/23
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
ARYA SCIENCES ACQUISITION CORP IV Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	06/04/23
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022	06/04/23
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	06/04/23
ARYA Sciences Acquisition IV : Non-Reliance on Previously Issued Financial Report - Form 8-K	05/04/23
ARYA SCIENCES ACQUISITION CORP IV : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	05/04/23
ARYA SCIENCES ACQUISITION CORP IV : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	01/03/23
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV	28/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ARYA Sciences Acquisition Corp IV

Azioni

ARYD

KYG316591083

Altre lingue

Filtri